MedTrace Logo

ADPKD Alterations in Hepatic Transporter Function

NCT03717883 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2020-03-25

No results posted yet for this study

Summary

This is a single center, comparative cohort study to investigate alterations in hepatic transporter function in subjects with autosomal dominant polycystic kidney disease (ADPKD) compared to healthy subjects and subjects with non-ADPKD renal disease. Eligible subjects will be 18-65 years of age and of any race/ethnicity and gender.

Conditions

  • ADPKD
  • Autosomal Dominant Polycystic Kidney Disease
  • Renal Disease

Sponsors & Collaborators

  • National Institute of General Medical Sciences (NIGMS)

    collaborator NIH

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Vimal Derebail, MD, MPH · University of North Carolina, Chapel Hill

  • Kim Brouwer, PharmD, PhD · University of North Carolina, Chapel Hill

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-17
Primary Completion
2020-01-29
Completion
2020-01-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03717883 on ClinicalTrials.gov